Skip to main content
Mukka Proteins Limited logo

Mukka Proteins Limited — Investor Relations & Filings

Ticker · MUKKA ISIN · INE0CG401037 LEI · 3358001F6BWKSFSZ2U02 BSE.NS Manufacturing
Open in API
Filings indexed 220 across all filing types
Latest filing 2024-08-13 Capital/Financing Update
Country IN India
Listing BSE.NS MUKKA

About Mukka Proteins Limited

https://mukkaproteins.com/

Mukka Proteins Limited specializes in the manufacture and supply of high-quality fish meal, fish oil, and fish soluble paste. The company serves as a critical supplier to the global aquafeed, poultry feed, and pet food sectors. Its core operations involve processing raw fish into nutrient-dense protein sources and essential fatty acids, including Omega-3. The product portfolio includes steam-dried fish meal and high-grade fish oil used in specialized animal nutrition formulations. Mukka Proteins maintains a robust supply chain and utilizes advanced processing technologies to ensure product consistency and nutritional integrity. The company caters to both domestic and international markets, positioning itself as a key provider of sustainable marine protein ingredients for the livestock and aquaculture sectors.

Recent filings

Filing Released Lang Actions
Updates
Capital/Financing Update Classification · 95% confidence The document is a formal letter addressed to stock exchanges (NSE and BSE) regarding an intimation under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. It informs about the Board of Directors' approval for issuance of a corporate guarantee and provision of security to another company. The document includes disclosure details as per SEBI circular requirements. The content is an announcement of a corporate action related to financing and guarantees, not a full financial report or audit. It is a regulatory announcement about a corporate guarantee and related disclosures, fitting the category of Capital/Financing Update (CAP). The document length is short and does not contain financial statements or detailed analysis, so it is not an Annual Report or Interim Report. It is not a report publication announcement or certification. Therefore, the best classification is Capital/Financing Update (CAP).
2024-08-13 English
Statement of deviation(s) or variation(s) under Reg. 32
Regulatory Filings Classification · 95% confidence The document is a statement of deviation or variation in the utilization of funds raised through an Initial Public Offering (IPO) for the quarter ended 30th June 2024. It references compliance with SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, and includes details about the amount raised, utilization, and confirmation of no deviation. The document is a regulatory compliance disclosure related to IPO fund usage, not a full financial report, earnings release, or management discussion. It is a formal regulatory filing to stock exchanges and does not contain financial statements or detailed analysis. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory announcements that do not fit other specific categories.
2024-08-13 English
Outcome of Board Meeting
Regulatory Filings
2024-08-13 English
Financial Result Updates
Regulatory Filings
2024-08-13 English
Updates
Regulatory Filings Classification · 95% confidence The document is an intimation under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, regarding a GST demand order received by the company. It includes details of the dispute, the opposing party, financial implications, and legal advice. The document is a regulatory announcement informing the stock exchanges about a material event affecting the company, specifically a legal/tax matter. It does not contain financial statements, earnings data, or detailed management discussion. It is not a full audit report or annual/interim report. It is not a voting result, capital change, or director dealing. The document fits best under Regulatory Filings (RNS) as a general regulatory announcement about a legal/tax issue disclosed as per SEBI regulations.
2024-08-12 English
Board Meeting — MUKKA PROTEINS LIMITED has informed the Exchange about Board Meeting to be held on 13-Aug-2024 to consider and approve the Quarterly Unaudited Financial results of the Company for the…
Regulatory Filings
2024-08-05 English

Browse filings by year

3 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.